Aruna V Sarma1, Jennifer L St Sauver2, Debra J Jacobson3, Michaela E McGree3, George G Klee4, Michael M Lieber5, Cynthia J Girman6, John M Hollingsworth7, Steven J Jacobsen8. 1. Department of Urology, University of Michigan, Ann Arbor, MI. Electronic address: asarma@umich.edu. 2. Division of Epidemiology, Mayo Clinic College of Medicine, Rochester, MN. 3. Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, MN. 4. Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN. 5. Department of Urology, Mayo Clinic College of Medicine, Rochester, MN. 6. Comparative and Outcomes Evidence Unit, Merck Research Laboratories, Blue Bell, PA. 7. Department of Urology, University of Michigan, Ann Arbor, MI. 8. Department of Research and Evaluation, Kaiser Permanente, Southern California, Pasadena, CA.
Abstract
OBJECTIVE: To determine the distribution of, and racial differences in, changes in prostate-specific antigen (PSA) from a population-based sample of men. MATERIALS AND METHODS: Data from 2 prospective cohort studies of a random sample of white men, aged 40-79 years in 1990, followed biennially through 2007, and African American men, aged 40-79 years in 1996, followed through 2000, were examined to assess the longitudinal changes in PSA concentrations. Serum PSA levels were determined at each examination for both cohorts and observations after a diagnosis of prostate cancer or treatment of benign prostatic hyperplasia were censored. The observed and estimated annual percentage of change in the serum PSA levels were examined by race. RESULTS: At baseline, the median PSA level in the white men did not differ from the median level observed in the African American men (white men 0.9 ng/mL; African American men 0.9 ng/mL; P = .48). However, African American men had a much more rapid increase in the PSA level over time compared with the white men (median annual percent change in PSA for white men 3.6%/y, African American men 7.9%/y; P <.001). CONCLUSION: These data suggest that African American men have more rapid rates of change in the PSA levels over time. If the difference in the rate of changes between African American and white men is an early indicator of future prostate cancer diagnosis, earlier detection in African American men could help to alleviate the racial disparities in prostate cancer diagnosis and mortality.
OBJECTIVE: To determine the distribution of, and racial differences in, changes in prostate-specific antigen (PSA) from a population-based sample of men. MATERIALS AND METHODS: Data from 2 prospective cohort studies of a random sample of white men, aged 40-79 years in 1990, followed biennially through 2007, and African American men, aged 40-79 years in 1996, followed through 2000, were examined to assess the longitudinal changes in PSA concentrations. Serum PSA levels were determined at each examination for both cohorts and observations after a diagnosis of prostate cancer or treatment of benign prostatic hyperplasia were censored. The observed and estimated annual percentage of change in the serum PSA levels were examined by race. RESULTS: At baseline, the median PSA level in the white men did not differ from the median level observed in the African American men (white men 0.9 ng/mL; African American men 0.9 ng/mL; P = .48). However, African American men had a much more rapid increase in the PSA level over time compared with the white men (median annual percent change in PSA for white men 3.6%/y, African American men 7.9%/y; P <.001). CONCLUSION: These data suggest that African American men have more rapid rates of change in the PSA levels over time. If the difference in the rate of changes between African American and white men is an early indicator of future prostate cancer diagnosis, earlier detection in African American men could help to alleviate the racial disparities in prostate cancer diagnosis and mortality.
Authors: Andreas P Berger; Martina Deibl; Hannes Steiner; Jasmin Bektic; Alexandre Pelzer; Robert Spranger; Helmut Klocker; Georg Bartsch; Wolfgang Horninger Journal: Prostate Date: 2005-08-01 Impact factor: 4.104
Authors: R J Henderson; J A Eastham; D J Culkin; M W Kattan; T Whatley; J Mata; D Venable; O Sartor Journal: J Natl Cancer Inst Date: 1997-01-15 Impact factor: 13.506
Authors: H B Carter; J D Pearson; E J Metter; L J Brant; D W Chan; R Andres; J L Fozard; P C Walsh Journal: JAMA Date: 1992 Apr 22-29 Impact factor: 56.272
Authors: Yong Hyun Park; In Young Choi; Sei Chul Yoon; Hong Seok Jang; Hyong Woo Moon; Sung-Hoo Hong; Sae Woong Kim; Tae-Kon Hwang; Ji Youl Lee Journal: Prostate Int Date: 2015-02-12